Arkolith/Insider Trading/ALMR/Form 4

Witney Frank

DirectorAlamar Biosciences, Inc. (ALMR) · full profile →Form 4 · filed Apr 20, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
0 non-derivative · 6 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 20, 2026Other(J)50K—$00
Apr 20, 2026Other(J)50K—$050K
Apr 20, 2026Other(J)33K—$00
Apr 20, 2026Other(J)33K—$033K
Apr 20, 2026Other(J)124K—$00
Apr 20, 2026Other(J)124K—$0124K

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001455312-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML